Cannabinoid Discrimination and Antagonism by CB(1) Neutral and Inverse Agonist Antagonists

Cannabinoid receptor 1 (CB(1)) inverse agonists (e.g., rimonabant) have been reported to produce adverse effects including nausea, emesis, and anhedonia that limit their clinical applications. Recent laboratory studies suggest that the effects of CB(1) neutral antagonists differ from those of such i...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: Kangas, Brian D., Delatte, Marcus S., Vemuri, V. Kiran, Thakur, Ganesh A., Nikas, Spyridon P., Subramanian, Kumara V., Shukla, Vidyanand G., Makriyannis, Alexandros, Bergman, Jack
التنسيق: Artigo
اللغة:Inglês
منشور في: The American Society for Pharmacology and Experimental Therapeutics 2013
الموضوعات:
Behavioral Pharmacology
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC3583508/
https://ncbi.nlm.nih.gov/pubmed/23287700
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1124/jpet.112.201962
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة